Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Double-blind, placebo-controlled, crossover trial of clozapine plus glycine in refractory schizophrenia negative results.

Literature DB >> 15876911

Double-blind, placebo-controlled, crossover trial of clozapine plus glycine in refractory schizophrenia negative results.

Pablo Diaz, Sreenivasa Bhaskara, Serdar M Dursun, Bill Deakin.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Clozapine
Glycine

Year: 2005 PMID： 15876911 DOI： 10.1097/01.jcp.0000165740.22377.6d

Source DB: PubMed Journal: J Clin Psychopharmacol ISSN： 0271-0749 Impact factor: 3.153

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

1. Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia.

Authors: Surendra P Singh; Vidhi Singh
Journal: CNS Drugs Date: 2011-10-01 Impact factor: 5.749

Review 2. Augmentation strategies in clozapine-resistant schizophrenia.

Authors: Gary Remington; Amitabha Saha; Siow-Ann Chong; Chekkera Shammi
Journal: CNS Drugs Date: 2005 Impact factor: 5.749

Review 3. Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials.

Authors: Y Iwata; S Nakajima; T Suzuki; R S E Keefe; E Plitman; J K Chung; F Caravaggio; M Mimura; A Graff-Guerrero; H Uchida
Journal: Mol Psychiatry Date: 2015-06-16 Impact factor: 15.992

Review 4. Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review.

Authors: Iris E Sommer; Marieke J H Begemann; Anke Temmerman; Stefan Leucht
Journal: Schizophr Bull Date: 2011-03-21 Impact factor: 9.306

Review 5. Neurobiological background of negative symptoms.

Authors: Silvana Galderisi; Eleonora Merlotti; Armida Mucci
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2015-03-24 Impact factor: 5.270

Review 6. Allosteric modulators for the treatment of schizophrenia: targeting glutamatergic networks.

Authors: Frank S Menniti; Craig W Lindsley; P Jeffrey Conn; Jayvardhan Pandit; Panayiotis Zagouras; Robert A Volkmann
Journal: Curr Top Med Chem Date: 2013 Impact factor: 3.295

Review 7. Multidimensional Connectomics and Treatment-Resistant Schizophrenia: Linking Phenotypic Circuits to Targeted Therapeutics.

Authors: Mary-Anne B MacKay; John W Paylor; James T F Wong; Ian R Winship; Glen B Baker; Serdar M Dursun
Journal: Front Psychiatry Date: 2018-10-30 Impact factor: 4.157